Literature DB >> 33229438

The SARS-CoV-2 envelope and membrane proteins modulate maturation and retention of the spike protein, allowing assembly of virus-like particles.

Bertrand Boson1, Vincent Legros2, Bingjie Zhou3, Eglantine Siret1, Cyrille Mathieu1, François-Loïc Cosset1, Dimitri Lavillette4, Solène Denolly5.   

Abstract

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a β-coronavirus, is the causative agent of the COVID-19 pandemic. Like for other coronaviruses, its particles are composed of four structural proteins: spike (S), envelope (E), membrane (M), and nucleoprotein (N) proteins. The involvement of each of these proteins and their interactions are critical for assembly and production of β-coronavirus particles. Here, we sought to characterize the interplay of SARS-CoV-2 structural proteins during the viral assembly process. By combining biochemical and imaging assays in infected versus transfected cells, we show that E and M regulate intracellular trafficking of S as well as its intracellular processing. Indeed, the imaging data reveal that S is relocalized at endoplasmic reticulum (ER)-Golgi intermediate compartment (ERGIC) or Golgi compartments upon coexpression of E or M, as observed in SARS-CoV-2-infected cells, which prevents syncytia formation. We show that a C-terminal retrieval motif in the cytoplasmic tail of S is required for its M-mediated retention in the ERGIC, whereas E induces S retention by modulating the cell secretory pathway. We also highlight that E and M induce a specific maturation of N-glycosylation of S, independently of the regulation of its localization, with a profile that is observed both in infected cells and in purified viral particles. Finally, we show that E, M, and N are required for optimal production of virus-like-particles. Altogether, these results highlight how E and M proteins may influence the properties of S proteins and promote the assembly of SARS-CoV-2 viral particles.
Copyright © 2020 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  COVID-19; SARS-CoV; glycoprotein; infectious disease; secretion; viral protein; virus assembly

Year:  2020        PMID: 33229438      PMCID: PMC7833635          DOI: 10.1074/jbc.RA120.016175

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  47 in total

Review 1.  Furin at the cutting edge: from protein traffic to embryogenesis and disease.

Authors:  Gary Thomas
Journal:  Nat Rev Mol Cell Biol       Date:  2002-10       Impact factor: 94.444

2.  Influenza virus M2 protein slows traffic along the secretory pathway. pH perturbation of acidified compartments affects early Golgi transport steps.

Authors:  J R Henkel; O A Weisz
Journal:  J Biol Chem       Date:  1998-03-13       Impact factor: 5.157

3.  Generation of synthetic severe acute respiratory syndrome coronavirus pseudoparticles: implications for assembly and vaccine production.

Authors:  Yue Huang; Zhi-yong Yang; Wing-pui Kong; Gary J Nabel
Journal:  J Virol       Date:  2004-11       Impact factor: 5.103

4.  Characterization and Treatment of SARS-CoV-2 in Nasal and Bronchial Human Airway Epithelia.

Authors:  Andrés Pizzorno; Blandine Padey; Thomas Julien; Sophie Trouillet-Assant; Aurélien Traversier; Elisabeth Errazuriz-Cerda; Julien Fouret; Julia Dubois; Alexandre Gaymard; François-Xavier Lescure; Victoria Dulière; Pauline Brun; Samuel Constant; Julien Poissy; Bruno Lina; Yazdan Yazdanpanah; Olivier Terrier; Manuel Rosa-Calatrava
Journal:  Cell Rep Med       Date:  2020-07-21

5.  Severe acute respiratory syndrome coronavirus envelope protein ion channel activity promotes virus fitness and pathogenesis.

Authors:  Jose L Nieto-Torres; Marta L DeDiego; Carmina Verdiá-Báguena; Jose M Jimenez-Guardeño; Jose A Regla-Nava; Raul Fernandez-Delgado; Carlos Castaño-Rodriguez; Antonio Alcaraz; Jaume Torres; Vicente M Aguilella; Luis Enjuanes
Journal:  PLoS Pathog       Date:  2014-05-01       Impact factor: 6.823

6.  The amino-terminus of the hepatitis C virus (HCV) p7 viroporin and its cleavage from glycoprotein E2-p7 precursor determine specific infectivity and secretion levels of HCV particle types.

Authors:  Solène Denolly; Chloé Mialon; Thomas Bourlet; Fouzia Amirache; François Penin; Brett Lindenbach; Bertrand Boson; François-Loïc Cosset
Journal:  PLoS Pathog       Date:  2017-12-18       Impact factor: 6.823

7.  More than one door - Budding of enveloped viruses through cellular membranes.

Authors:  Sonja Welsch; Barbara Müller; Hans-Georg Kräusslich
Journal:  FEBS Lett       Date:  2007-03-30       Impact factor: 4.124

8.  Coronavirus E protein forms ion channels with functionally and structurally-involved membrane lipids.

Authors:  Carmina Verdiá-Báguena; Jose L Nieto-Torres; Antonio Alcaraz; Marta L DeDiego; Jaume Torres; Vicente M Aguilella; Luis Enjuanes
Journal:  Virology       Date:  2012-07-24       Impact factor: 3.616

9.  A single polar residue and distinct membrane topologies impact the function of the infectious bronchitis coronavirus E protein.

Authors:  Travis R Ruch; Carolyn E Machamer
Journal:  PLoS Pathog       Date:  2012-05-03       Impact factor: 6.823

10.  Broadening of neutralization activity to directly block a dominant antibody-driven SARS-coronavirus evolution pathway.

Authors:  Jianhua Sui; Daniel R Aird; Azaibi Tamin; Akikazu Murakami; Meiying Yan; Anuradha Yammanuru; Huaiqi Jing; Biao Kan; Xin Liu; Quan Zhu; Qing-An Yuan; Gregory P Adams; William J Bellini; Jianguo Xu; Larry J Anderson; Wayne A Marasco
Journal:  PLoS Pathog       Date:  2008-11-07       Impact factor: 6.823

View more
  55 in total

1.  SARS-CoV-2 Envelope Protein Forms Clustered Pentamers in Lipid Bilayers.

Authors:  Noah H Somberg; Westley W Wu; João Medeiros-Silva; Aurelio J Dregni; Hyunil Jo; William F DeGrado; Mei Hong
Journal:  Biochemistry       Date:  2022-10-11       Impact factor: 3.321

2.  Electrospun nanofibrous membrane with antibacterial and antiviral properties decorated with Myoporum bontioides extract and silver-doped carbon nitride nanoparticles for medical masks application.

Authors:  Pinhong Chen; Zhi Yang; Zhuoxian Mai; Ziyun Huang; Yongshuang Bian; Shangjing Wu; Xianming Dong; Xianjun Fu; Frank Ko; Shiying Zhang; Wenxu Zheng; Shengsen Zhang; Wuyi Zhou
Journal:  Sep Purif Technol       Date:  2022-06-24       Impact factor: 9.136

Review 3.  Comparison of Cell Fusions Induced by Influenza Virus and SARS-CoV-2.

Authors:  Chuyuan Zhang; Xinjie Meng; Hanjun Zhao
Journal:  Int J Mol Sci       Date:  2022-07-01       Impact factor: 6.208

4.  Probing effects of the SARS-CoV-2 E protein on membrane curvature and intracellular calcium.

Authors:  Aujan Mehregan; Sergio Pérez-Conesa; Yuxuan Zhuang; Ahmad Elbahnsi; Diletta Pasini; Erik Lindahl; Rebecca J Howard; Chris Ulens; Lucie Delemotte
Journal:  Biochim Biophys Acta Biomembr       Date:  2022-06-18       Impact factor: 4.019

5.  SARS-CoV-2 Delta spike protein enhances the viral fusogenicity and inflammatory cytokine production.

Authors:  Zhujun Ao; Maggie Jing Ouyang; Titus Abiola Olukitibi; Xiaojian Yao
Journal:  iScience       Date:  2022-07-14

6.  Linking COVID-19 and Heme-Driven Pathophysiologies: A Combined Computational-Experimental Approach.

Authors:  Marie-Thérèse Hopp; Daniel Domingo-Fernández; Yojana Gadiya; Milena S Detzel; Regina Graf; Benjamin F Schmalohr; Alpha T Kodamullil; Diana Imhof; Martin Hofmann-Apitius
Journal:  Biomolecules       Date:  2021-04-27

7.  A weak COPI binding motif in the cytoplasmic tail of SARS-CoV-2 spike glycoprotein is necessary for its cleavage, glycosylation, and localization.

Authors:  Benjamin C Jennings; Stuart Kornfeld; Balraj Doray
Journal:  FEBS Lett       Date:  2021-05-26       Impact factor: 3.864

8.  Rotavirus as an Expression Platform of Domains of the SARS-CoV-2 Spike Protein.

Authors:  Asha Ann Philip; John Thomas Patton
Journal:  Vaccines (Basel)       Date:  2021-05-03

Review 9.  Glycosylation of SARS-CoV-2: structural and functional insights.

Authors:  Asif Shajahan; Lauren E Pepi; Daniel S Rouhani; Christian Heiss; Parastoo Azadi
Journal:  Anal Bioanal Chem       Date:  2021-07-07       Impact factor: 4.478

Review 10.  COVID-19: Myths and Reality.

Authors:  Larisa V Kordyukova; Andrey V Shanko
Journal:  Biochemistry (Mosc)       Date:  2021-07       Impact factor: 2.487

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.